Effects of 17β-estradiol and trimegestone alone, and in combination, on the bone and uterus of ovariectomized rats

Gynecological Endocrinology

Volumn 15, Issue 4, 2001, Pages 312-320

  Lepescheux, L ^a   Secchi, J ^a   Gaillard Kelly, M ^a   Miller, P ^a  

^a SANOFI   (France)

Author keywords

17 Estradiol; Bone; Ovariectomized Rat; Trimegestone; Uterus

Indexed keywords

ESTRADIOL; NORETHISTERONE; TRIMEGESTONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE; BONE MASS; CONTROLLED STUDY; DRUG INHIBITION; FEMALE; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROPHYLAXIS; RAT; UTERUS;

EID: 0034852976     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/713602879     Document Type: Article

References (9)

1. The pharmacological profile of a novel norpregnane progestin (trimegestone)
2. In vitro characterization of trimegestone: A new potent and selective progestin
3. Hormone therapy to prevent disease and prolong life in postmenopausal women
4. A multiple comparison procedure for comparing several treatments with a control
5. The aged rat model of ovarian hormone deficiency bone loss
6. The ovariectomized rat as an animal model for postmenopausal bone loss
7. The rat as a model for studies of the ageing skeleton
8. Long-term effects of ovariectomy and ageing on the rat skeleton
9. Estrogen does not restore bone loss after ovariectomy in the rat